eConsent Solutions
-
How Can Phase 1 Trials Employ eClinical Solutions?
1/8/2024
Uncover how this unified platform is helping sponsors and CROs generate high-quality data, accelerate trials, and rapidly scale to Phase 2 and beyond.
-
Empower Patients To Make Informed Decisions
11/8/2022
YPrime’s eConsent platform and patient-centered approach ensure better comprehension of complex information, accelerate enrollment and screening, and improve patient engagement.
-
Medable Studio
9/16/2024
More than just a builder, Medable Studio offers unmatched control over study creation and launch, eliminating the common roadblocks of study startup and empowering users throughout the process.
-
Introducing One Home for Sites™
2/8/2024
One Home for Sites is a vendor-agnostic, sponsor-agnostic, aggregation platform that provides single sign-on and more. Become part of the only industry-wide solution to site tech overload.
-
Just The Facts: Direct Data Capture
5/20/2022
Start enabling direct data capture (DDC), clinical outcome assessments (eCOA), patient reported outcomes (ePRO), and eConsent with the Clinical ink platform.
-
Unified, Integrated eClinical Research Solutions
1/16/2024
Facilitate efficient digitalization and optimization of clinical trials that meet the unique needs of small and mid-size biopharma organizations with the Signant SmartSignals Unified Platform.
-
EDC: Control Your Data, Control Your Study
2/16/2023
Streamline data, maximize efficiencies, tighten up costs, and reach end goals faster using Medrio’s powerful and intuitive EDC tool.
-
Improving Trial Efficiency With eClinical Solutions
10/24/2023
Clinical development organizations looking for efficient, expedient, and agile technology solutions should see how leveraging an eClinical suite with unified solutions and a single database can drive efficiency.
-
One Home for Sites™ Partnership Program Guide
4/7/2024
Learn how your organization can become part of One Home for Sites, the only platform that’s bringing the industry together to help sites survive and thrive, along with their patients.
-
End-To-End Digital Therapeutics Studies Powered By Technology
2/2/2023
Curebase offers a variety of decentralized study models designed and tested for any type of DTx trial.